Earnings Call · Q2 FY2022·2022-08-07

Q2 22EPS +6.49%·Rev n/aQ1 22EPS -16.57%·Rev n/aQ4 21EPS -32.35%·Rev n/aQ3 21EPS -7.04%·Rev n/a⚠ consensus missing

X4 Pharmaceuticals, Inc XFOR

Dan Ferry — Investor Relations or Conference Call Moderator

Dr. Paula Ragan — Chief Executive Officer

Adam Mostafa — Chief Financial Officer

−1.6%1d on move date−1.5% vs SPY3d−9.3%5d−0.8%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more XFOR calls or request research access.

More XFOR calls Browse calls Request research access